SARS CoV-2 HexaPro spike (bio-His) Citations (4)
Originally described in: SARS-CoV-2 spike-specific memory B cells express higher levels of T-bet and FcRL5 after non-severe COVID-19 as compared to severe disease.Reyes RA, Clarke K, Gonzales SJ, Cantwell AM, Garza R, Catano G, Tragus RE, Patterson TF, Bol S, Bunnik EM PLoS One. 2021 Dec 22;16(12):e0261656. doi: 10.1371/journal.pone.0261656. eCollection 2021. PubMed Journal
Articles Citing SARS CoV-2 HexaPro spike (bio-His)
| Articles |
|---|
| SARS-CoV-2 spike-specific memory B cells express markers of durable immunity after non-severe COVID-19 but not after severe disease. Reyes RA, Clarke K, Gonzales SJ, Cantwell AM, Garza R, Catano G, Tragus RE, Patterson TF, Bol S, Bunnik EM. bioRxiv. 2021 Sep 27. doi: 10.1101/2021.09.24.461732. PubMed |
SARS-CoV-2 spike-specific memory B cells express higher levels of T-bet and FcRL5 after non-severe COVID-19 as compared to severe disease.
Reyes RA, Clarke K, Gonzales SJ, Cantwell AM, Garza R, Catano G, Tragus RE, Patterson TF, Bol S, Bunnik EM.
PLoS One. 2021 Dec 22;16(12):e0261656. doi: 10.1371/journal.pone.0261656. eCollection 2021.
PubMed
Associated Plasmids |
| Targeting Spike Glycans to Inhibit SARS-CoV2 Viral Entry. Guseman AJ, Rennick LJ, Nambulli S, Roy CN, Martinez DR, Yang DT, Bhinderwhala F, Vergara S, Baric RS, Ambrose Z, Duprex WP, Gronenborn AM. bioRxiv. 2022 Dec 22:2022.12.22.521642. doi: 10.1101/2022.12.22.521642. Preprint. PubMed |
| Targeting spike glycans to inhibit SARS-CoV2 viral entry. Guseman AJ, Rennick LJ, Nambulli S, Roy CN, Martinez DR, Yang DT, Bhinderwala F, Vergara S, Schaefer A, Baric RS, Ambrose Z, Duprex WP, Gronenborn AM. Proc Natl Acad Sci U S A. 2023 Sep 19;120(38):e2301518120. doi: 10.1073/pnas.2301518120. Epub 2023 Sep 11. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.